Journal rankings · indicator year 2024
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2024
Nephrology journal rankings 2024
65 ranked journals · Subfield in Medicine
Nephrology has 65 ranked journals in 2024. The median journal has an OJR of 0.70, below the world average of 1.00, up 0.02 on 2023; Q1 starts at OJR 0.98. The top three are Nature Reviews Nephrology, Kidney International, and Journal of the American Society of Nephrology.
Ranks and citation indicators: 2024. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2021–2023, the window the 2024 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
- Nephrology65
Show all 42 subfields
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Hematology83
- Rheumatology67
- Complementary and alternative medicine59
- Reproductive Medicine52
- Pharmacology49
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Hepatology30
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
65 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2023. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2021–2023, the window the 2024 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2021–2023 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2015 to 2024. | Compare |
|---|---|---|---|---|---|---|---|
1Nature Reviews NephrologyNature Portfolio · United Kingdom | 3.17Q1 | 16.95 5.05 up from 2023 | 386 | 30% | — | ||
2Kidney InternationalElsevier BV · Netherlands | 2.41Q1 | 6.57 0.97 down from 2023 | 1,033 | 50% | $3,500 | ||
3Journal of the American Society of NephrologyAmerican Society of Nephrology | 2.13Q1 | 5.65 1.00 down from 2023 | 777 | 7% | — | ||
4American Journal of Kidney DiseasesElsevier BV · United States | 2.05Q1 | 5.08 0.56 down from 2023 | 645 | 21% | $3,900 | ||
5Clinical Journal of the American Society of NephrologyLippincott Williams & Wilkins · United States | 1.77Q1 | 4.27 0.69 down from 2023 | 828 | 91% | — | ||
6American Journal of NephrologyKarger Publishers · Switzerland | 1.52Q1 | 3.25 1.36 down from 2023 | 252 | 51% | — | ||
7Clinical Kidney JournalOAOxford University Press · United Kingdom | 1.45Q1 | 4.00 0.18 up from 2023 | 835 | 100% | $3,335 | ||
8Nephrology Dialysis TransplantationOxford University Press · United Kingdom | 1.42Q1 | 3.91 0.26 down from 2023 | 945 | 74% | $3,926 | ||
9Seminars in NephrologyElsevier BV · United States | 1.36Q1 | 3.42 0.83 up from 2023 | 181 | 34% | $3,500 | ||
10Advances in Kidney Disease and HealthPublisher not listed | 1.29Q1 | 2.91 1.16 up from 2023 | 56 | 32% | $3,200 | ||
11Kidney International ReportsOAElsevier BV · United States | 1.22Q1 | 3.51 0.13 down from 2023 | 1,153 | 100% | $2,800 | ||
12Kidney DiseasesOAKarger Publishers · Switzerland | 1.19Q1 | 3.51 0.12 up from 2023 | 131 | 100% | $2,320 | ||
13Advances in Chronic Kidney DiseaseElsevier BV · United States | 1.13Q1 | 2.30 0.15 down from 2023 | 136 | — | $2,900 | ||
14Peritoneal Dialysis InternationalSAGE Publishing · United Kingdom | 1.09Q1 | 3.57 0.07 up from 2023 | 182 | 37% | $4,150 | ||
15Kidney Research and Clinical PracticeOAElsevier BV · South Korea | 1.03Q1 | 2.96 0.03 up from 2023 | 269 | 100% | — | ||
16BMC NephrologyOABioMed Central · United Kingdom | 1.01Q1 | 2.96 0.09 up from 2023 | 1,192 | 100% | $3,090 | ||
17Renal FailureOATaylor & Francis · United States | 0.98Q1 | 3.20 0.04 up from 2023 | 728 | 100% | $2,306 | ||
18Kidney MedicineOAElsevier BV · United States | 0.95Q2 | 2.90 0.44 up from 2023 | 516 | 100% | $2,590 | ||
19Current Opinion in Nephrology & HypertensionLippincott Williams & Wilkins · United States | 0.92Q2 | 2.51 0.05 down from 2023 | 229 | 40% | — | ||
20Cardiorenal MedicineOAKarger Publishers · Switzerland | 0.89Q2 | 2.53 0.64 down from 2023 | 75 | 100% | — | ||
21World Journal of NephrologyOABaishideng Publishing Group · United States | 0.88Q2 | 2.55 0.24 down from 2023 | 42 | 100% | — | ||
22Kidney360OALippincott Williams & Wilkins · United States | 0.88Q2 | 2.23 0.30 down from 2023 | 836 | 100% | — | ||
23International Journal of Nephrology and Renovascular DiseaseOADove Medical Press · New Zealand | 0.88Q2 | 2.88 0.34 up from 2023 | 103 | 100% | $2,320 | ||
24Frontiers in NephrologyOAFrontiers Media · Switzerland | 0.86Q2 | 2.25 1.41 up from 2023 | 106 | 100% | $2,353 | ||
25Pediatric NephrologySpringer Science+Business Media · United States | 0.85Q2 | 2.59 0.11 up from 2023 | 1,202 | 54% | $4,337 | ||
26Kidney & Blood Pressure ResearchOAKarger Publishers · Switzerland | 0.84Q2 | 2.50 0.21 down from 2023 | 205 | 100% | $2,780 | ||
27Journal of Renal NutritionElsevier BV · United States | 0.79Q2 | 2.78 0.08 down from 2023 | 293 | 36% | $3,490 | ||
28International Journal of NephrologyOAHindawi Publishing Corporation · United Kingdom | 0.77Q2 | 1.81 0.64 down from 2023 | 108 | 100% | $1,000 | ||
29Kidney and DialysisOASwitzerland | 0.77Q2 | 2.61 1.15 up from 2023 | 110 | 100% | $1,207 | ||
30The Nephron journals/Nephron journalsPublisher not listed | 0.74Q2 | 1.97 0.40 down from 2023 | 349 | 39% | — | ||
31Blood PurificationKarger Publishers · Switzerland | 0.73Q2 | 2.33 0.08 down from 2023 | 275 | 36% | — | ||
32Journal of NephrologySpringer Science+Business Media · Italy | 0.71Q2 | 2.10 0.50 down from 2023 | 847 | 41% | $4,337 | ||
33International Urology and NephrologySpringer Science+Business Media · Hungary | 0.70Q2 | 1.99 0.01 up from 2023 | 1,162 | 18% | $3,690 | ||
34Journal of Renal CareWiley · France | 0.70Q3 | 1.63 0.01 down from 2023 | 95 | 69% | $3,350 | ||
35Clinical and Experimental NephrologySpringer Science+Business Media · Japan | 0.70Q3 | 1.78 0.46 down from 2023 | 415 | 40% | $3,990 | ||
36Glomerular DiseasesOAKarger Publishers | 0.67Q3 | 1.61 0.10 up from 2023 | 78 | 100% | $990 | ||
37NephrologyWiley · Australia | 0.63Q3 | 1.75 0.30 down from 2023 | 327 | 70% | $4,110 | ||
38Seminars in DialysisWiley · United States | 0.61Q3 | 1.19 0.59 down from 2023 | 227 | 54% | $3,730 | ||
39Canadian Journal of Kidney Health and DiseaseOASAGE Publishing · United Kingdom | 0.59Q3 | 1.73 0.39 down from 2023 | 273 | 100% | $2,000 | ||
40Hemodialysis InternationalWiley · Canada | 0.50Q3 | 1.31 0.03 down from 2023 | 207 | 55% | $3,700 | ||
41Revista de investigaci�n Cl�nicaOAPermanyer · Mexico | 0.45Q3 | 1.48 0.10 up from 2023 | 108 | 100% | $2,000 | ||
42Renal Replacement TherapyOABioMed Central · United Kingdom | 0.45Q3 | 1.32 0.26 up from 2023 | 195 | 100% | $0 listed | ||
43Therapeutic Apheresis and DialysisWiley · United Kingdom | 0.40Q3 | 1.13 0.35 down from 2023 | 417 | 46% | $3,350 | ||
44Nefrología (English Edition)OAElsevier BV · Spain | 0.38Q3 | 1.10 0.14 up from 2023 | 390 | 100% | $0 listed | ||
45Case Reports in Nephrology and DialysisOAKarger Publishers · Switzerland | 0.38Q3 | 1.21 0.12 up from 2023 | 114 | 100% | $1,030 | ||
46Brazilian Journal of NephrologyOASociedade Brasileira de Nefrologia · Brazil | 0.37Q3 | 0.90 1.14 down from 2023 | 379 | 100% | — | ||
47CEN Case ReportsSpringer Science+Business Media · Japan | 0.34Q3 | 0.94 0.39 down from 2023 | 286 | 100% | $4,090 | ||
48Clinical NephrologyDustri-Verlag · Germany | 0.33Q3 | 0.78 0.18 down from 2023 | 304 | 5% | — | ||
49Néphrologie & ThérapeutiqueElsevier BV · France | 0.31Q3 | 0.59 0.18 down from 2023 | 177 | 12% | $1,780 | ||
50Nephrology Nursing JournalAmerican Nephrology Nurses Association · United States | 0.29Q4 | 0.51 0.04 down from 2023 | 160 | 2% | — |
Subfields of Medicine, with Nephrology highlighted.
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Hematology83
- Rheumatology67
- Nephrology65
- Complementary and alternative medicine59
- Reproductive Medicine52
- Pharmacology49
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Hepatology30
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2024. Corpus-wide, 87.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
12 additional Nephrology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2021–2023, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2024. Publication window: 2021–2023. How these summaries are calculated
- Ranked journals
- 65
- Window papers (baseline)
- 34,449 +11.6% from indicator year 2021
- Median OJR
- 0.704 -4.0% from indicator year 2021
- Rising journals (2025)
- 7
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2021–2023 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 21 | 24 | 26 | 27 | 28 | 31 | 34 | 34 | 33 | 37 | 37 | 41 | 40 | 46 | 51 | 49 | 53 | 58 | 59 | 58 | 58 | 61 | 62 | 65 | 65 | 62 | |
| Window papers (baseline) | 7,102 | 8,233 | 8,876 | 9,713 | 10,062 | 10,968 | 12,092 | 13,345 | 14,934 | 18,910 | 20,526 | 22,005 | 21,127 | 22,388 | 23,923 | 24,984 | 25,880 | 26,465 | 27,233 | 28,141 | 29,154 | 30,871 | 32,776 | 34,022 | 34,449 | 35,470 | |
| Median OJR | 0.58 | 0.476 | 0.483 | 0.62 | 0.57 | 0.60 | 0.63 | 0.67 | 0.728 | 0.703 | 0.721 | 0.716 | 0.82 | 0.750 | 0.730 | 0.85 | 0.81 | 0.747 | 0.84 | 0.80 | 0.83 | 0.733 | 0.755 | 0.68 | 0.704 | 0.724 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.